Teladoc Health, Inc. (TDOC) · Sep 25, 2026 · Exec change

Teladoc CLO resigns for “good reason,” with internal successor lined up

CLO departure — Resigns November 1; internal successor assumes role

Teladoc’s chief legal officer will resign November 1 under his severance agreement. An internal promotion and unpaid transition role contain the operational risk.

Teladoc is trying to build more disciplined, integrated virtual care while stabilizing a weaker BetterHelp business: Integrated Care grew modestly in the second quarter of 2026, while BetterHelp revenue fell 12% year over year. Against that backdrop, this filing is a management-continuity event—not a change to the operating strategy.

The departure is a modest negative, but not an operational rupture. Chief Legal Officer Adam Vandervoort is resigning effective November 1, 2026, and the filing says the resignation was made with “good reason” under his executive severance agreement. 〔0〕 The filing does not explain what triggered that provision, so the underlying issue is unclear; the severance reference adds some uncertainty beyond a routine retirement or planned handoff.

Internal succession materially reduces execution risk. Jonathan Dorfman, already the company’s Senior Vice President of Securities & Corporate Law, will become chief legal officer and secretary. 〔1〕 That points to continuity in legal and corporate-law oversight rather than an externally driven leadership reset.

The transition is unusually extended and cost-controlled. Vandervoort will provide advisory services through November 1, 2027, but without compensation. 〔2〕 That should preserve institutional knowledge during the handoff without creating a new ongoing pay obligation, although the year-long advisory period suggests the company wants a careful transition of responsibilities.

Bottom line: This is a fresh leadership change with a mildly negative initial signal because the resignation invokes “good reason,” but the internal replacement and extended unpaid handoff keep it from becoming a meaningful disruption to Teladoc’s broader business transition.

What to watch next

Internal successor takes over November 1

Original filing on SEC EDGAR

More Teladoc Health, Inc. news

Teladoc CLO resigns for “good reason,” with internal successor lined up | TDOC Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.